TUDOR INVESTMENT CORP ET AL - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,396
-99.9%
30,799
+46.4%
0.03%
-31.7%
Q1 2022$1,730,000
+124.4%
21,040
+382.6%
0.04%
+215.4%
Q3 2021$771,000
-83.3%
4,360
-84.7%
0.01%
-85.1%
Q2 2021$4,615,000
+71.1%
28,568
+75.9%
0.09%
-25.6%
Q3 2020$2,697,000
+727.3%
16,242
+468.1%
0.12%
+631.2%
Q2 2020$326,000
+210.5%
2,859
-82.1%
0.02%
+700.0%
Q3 2016$105,000
-58.2%
15,957
-65.2%
0.00%
-60.0%
Q2 2016$251,000
-27.0%
45,900
+359.4%
0.01%
-58.3%
Q3 2015$344,0009,9910.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders